| Levosimendan: a promising treatment for myocardial stunning? | |
| | |
MedLine Citation:
|
PMID: 16409345 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
We report a case of a 55-year-old male undergoing major orofacial cancer surgery. A stent to the left anterior descending artery had been implanted for ischaemic heart disease 3 years previously. Twenty-four hours after uneventful anaesthesia and surgery, the patient developed myocardial infarction and cardiogenic shock. Immediate percutaneous transluminal coronary angioplasty, intra aortic balloon counterpulsation, and catecholamine therapy failed to stabilise haemodynamics. In light of successful reperfusion therapy and an only moderate elevation of troponin I, myocardial stunning rather than myonecrosis was considered to be the major contributor to life-threatening left ventricular failure. Therefore, the calcium-sensitising drug levosimendan, which exerts positive inotropic activity without increasing myocardial oxygen demand, was administered as a rescue medication. Within 24 h, levosimendan resulted in decreased filling pressures, reduced left ventricular end-diastolic volume, and augmented systemic pressures. Seven days following surgery, the patient was discharged from the intensive care unit in good clinical condition. |
| | |
Authors:
|
B M Ellger; P K Zahn; H K Van Aken; C Schmidt; T Brussel |
Related Documents
:
|
11401945 - Assessment of global atrial fibrillation organization to optimize timing of atrial defi... 18060935 - Pregnancy-associated spontaneous coronary artery dissection. 9533375 - Efficacy of low-energy t wave shocks for induction of ventricular fibrillation in patie... 21067535 - Clinical review: mechanical circulatory support for cardiogenic shock complicating acut... 10585085 - Left superior vena cava to the left atrium: do we have to change the traditional approach? 7277155 - Use of military antishock trouser in a child. |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Anaesthesia Volume: 61 ISSN: 0003-2409 ISO Abbreviation: Anaesthesia Publication Date: 2006 Jan |
Date Detail:
|
Created Date: 2006-01-13 Completed Date: 2006-01-27 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0370524 Medline TA: Anaesthesia Country: England |
Other Details:
|
Languages: eng Pagination: 61-3 Citation Subset: AIM; IM |
Affiliation:
|
Department of Anaesthesiology and Surgical Intensive Care Medicine, University of Muenster Hospital, D-48129 Muenster, Germany. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Cardiotonic Agents
/
therapeutic use* Facial Neoplasms / surgery Humans Hydrazones / therapeutic use* Male Middle Aged Myocardial Ischemia / complications Myocardial Stunning / drug therapy* Postoperative Complications / drug therapy* Pyridazines / therapeutic use* |
| Chemical | |
Reg. No./Substance:
|
0/Cardiotonic Agents; 0/Hydrazones; 0/Pyridazines; 131741-08-7/simendan |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Botulism in a pregnant intravenous drug abuser.
Next Document: Evolutionary and functional analysis of the tailless enhancer in Musca domestica and Drosophila mela...